Comparative assessment of effects of calcium channel antagonists, amlodipine, and cilnidipine, on QT interval in hypertensive patients - An observational study
Journal Title: National Journal of Physiology, Pharmacy and Pharmacology - Year 2018, Vol 8, Issue 4
Abstract
Background: The duration of the QT interval as measured by 12-lead electrocardiography is a measure of myocardial repolarization and is widely used to describe cardiac abnormalities, to determine the presence of cardiac toxicity and to evaluate drug safety. In hypertension, the QT interval is a predictor of the risk of both coronary events and cardiovascular death, after adjusting for the effects of additional risk factors. According to AHA and JNC VIII calcium channel blockers are first-line drug in the treatment of hypertension. The equipotent antihypertensive effect of cilnidipine and amlodipine in their equivalent dose has been demonstrated in number of studies. Aims and Objectives: To compare and evaluate the effects of calcium channel antagonists amlodipine and cilnidipine on QT interval among hypertensive patients. Materials and Methods: A total of 258 patients were screened, examined, and enrolled as study participants during that period. The enrolled patients were then divided as (1) hypertensive patient (n = 159) - selected patients received either amlodipine (2.5–10 mg) or cilnidipine (5–20 mg) with or without angiotensin receptor blocker (ARB) and (2) hypertensive with controlled diabetic patients (n = 99) - selected patients received either amlodipine (2.5–10 mg) or cilnidipine (5–20 mg) with or without ARB along with antidiabetic medication. Calculated by Bazett’s formula (most commonly used) = QT Interval/√ (relative risk [RR] interval) where RR interval = 60/heart rate, normal QTc ≤440 ms. The QT interval was measured at the baseline and after 12 months of treatment for hypertensive patients. Results: There was extremely significant QTc reduction was seen with cilnidipine therapy and significant elevation seen by amlodipine treatment but without any clinical relevance. While comparing the effect of amlodipine and cilnidipine, extremely significant as well as clinically relevant difference between the two treatments was noted. Conclusions: From this study, it can be concluded that cilnidipine reduces QTc interval, and hence is a better choice over amlodipine for patients suffering from long QT interval.
Authors and Affiliations
Sougata Sarkar, Vartika Srivastava, Manjushree Mohanty
Keywords
Related Articles
- EP ID EP487768
- DOI 10.5455/njppp.2017.7.0937418112017
- Views 69
- Downloads 0
Blood group distribution and its relationship with bleeding time and clotting time
Background: Blood group plays a vital role in the field of transfusion medicine. The relationship between bleeding time, clotting time, and blood group is important in certain clinical conditions such as epistaxis...
Gender differences in internet preferences and usage pattern among medical students
Background: Internet began with the development of electronic computers in the 1950s. Internet use is spreading rapidly into daily life, and directly affecting people’s ideas and behavior. With the development of the int...
Immediate effect of slow right and left nostril deep breathing exercises on reaction time, pain sensitivity, and temperature of elderly population in Madurai
Background: Falls and fractures are very common in the elderly due to reduced swiftness of the response, decreased attention, and concentration. Normal reference point of temperature and pain threshold also varies in old...
Investigating the validity of allometrically designed equations to estimate VO2max in Iranian boys
Background: Cardiac respiratory system plays an important role in individuals’ health, promotion of patients’ life quality, and professional athletes’ performance. It is of great importance to measure it for exchange of...
Serum interleukin-6 and body mass index among diabetic patients in Manipur
Background: Diabetes mellitus has emerged as a state of low-grade chronic inflammation. Interleukin-6 (IL-6) has evolved as a regulator of glucose homeostasis apart from it is immunoregulatory action. Body mass index (BM...